Vaccine Adjuvants Market
Vaccine Adjuvants Market Analysis by Adjuvant Emulsions, Pathogen Components, Saponin-based Adjuvants, Particulate Adjuvants, and Other Products from 2023 to 2033
Analysis of Vaccine Adjuvants Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Vaccine Adjuvants Market Outlook (2023 to 2033)
Newly-released vaccine adjuvants market analysis report by Fact.MR reveals that global sales of the Vaccine Adjuvants in 2022 were held at US$ 1.9 Billion. With 12.3% projected growth from 2023 to 2033, the market is expected to reach a valuation of US$ 6.8 Billion by the end of the forecast period.
Adjuvant emulsions are expected to be the significant revenue-generating type in the market, projected to grow at a CAGR of over 12.1% from 2023 to 2033.
| Attributes | Details |
|---|---|
|
Global Vaccine Adjuvants Market Size (2022) |
US$ 1.9 Billion |
|
Global Vaccine Adjuvants Market Size (2033) |
US$ 6.8 Billion |
|
Global Vaccine Adjuvants Market CAGR (2023 to 2033) |
12.3% |
|
U.S. Vaccine Adjuvants Market CAGR (2023 to 2033) |
12% |
|
Key Companies Covered |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue of Vaccine Adjuvants Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033
As per the research of the vaccine adjuvants market by Fact.MR - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around 14.6% CAGR. With an absolute dollar opportunity of US$ 4.7 Billion, the market is projected to reach a valuation of US$ 6.8 Billion by 2033.
What Key Drivers are Influencing the Market Expansion?
The key drivers influencing vaccine adjuvants market expansion include rising demand for vaccines, advancement in biotechnology, a growing number of people with infectious diseases, government funding, and increasing investment in R&D.
Vaccine adjuvants are substances that are added to vaccines to boost the immune response and increase the effectiveness of the vaccine. This is used for the preparation of human vaccines and veterinary vaccines. The human vaccine includes diabetes, cancer, Tuberculosis, Influenza, COVID-19, and BCG vaccines. Vaccine adjuvants are used for the prevention and treatment of various types of infectious diseases.
In 2019, According to International Diabetes Federation, people between the age group 20 to 79 suffered from diabetes, and the number accounted to be 463 million worldwide. Diabetic vaccines are playing a significant role in the prevention and treatment of diabetes. So the demand for a more effective vaccine has increased. Vaccines that contain adjuvants are more long-lasting, immune, and more effective. As a result, there is a growing demand for vaccine adjuvants for prevention and treatment.
In 2021, Adjuvant Capital, a life science investment firm raised US$ 300 million for companies that are producing vaccines and adjuvants for infectious diseases. The investment in vaccine adjuvants has increased in the last few years which is expected to escalate the market growth.
Several companies formed collaborations and partnerships for the development of new vaccines and vaccine adjuvants. Advax a novel adjuvant that is used in the COVID-19 vaccine was developed by Vaxine Pty Ltd with the partnership firm Medytox. Due to these factors, the demand for vaccine adjuvants is expected to increase.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Region-Wise Analysis
Which Region is Projected to Offer Significant Growth in the Market?
North America is a prominent shareholder in the market with a market size of US$ 780 million in 2022 and is estimated to reach US$ 879 million in 2023. It is projected that the region will have a market worth US$ 2.7 Billion by 2033.
In 2020, liver cancer was the third leading cause of death worldwide. Over 830 thousand people were diagnosed and 41 thousand people died due to liver cancer in the United States. The hepatitis-B vaccine is used for the prevention and treatment of liver cancer. Due to the increasing demand for vaccines and vaccine adjuvants, the vaccine adjuvant market is expected to rise.
Country-Wise Analysis
United States Vaccine Adjuvants Market Analysis :
The market in the United States is expected to grow to be worth US$ 2.4 Billion by 2033, with an absolute dollar growth of US$ 1.6 Billion from 2023 to 2033. The market in the United States has grown at a CAGR of 14.2% from 2018 to 2022 and is expected to grow at a CAGR of 12% from the year 2023 to 2033.
United Kingdom Vaccine Adjuvants Market Analysis :
The market in the United Kingdom is expected to grow to be worth US$ 261.2 million by 2033, with an absolute dollar growth of US$ 171.6 million. The market in the United Kingdom has grown at a CAGR of 12.9% from 2018 to 2022 and is expected to grow at a CAGR of 11.3% from 2023 to 2033.
In 2019, around 387 thousand cases were diagnosed with cancer, and around 166 thousand deaths were reported in the United Kingdom. In cancer vaccines, adjuvants are used to stimulate the immune system to recognize and attack cancer cells. As a result, there is a growing demand for vaccine adjuvants for the prevention and treatment of cancer. Thus, it is expected to propel the market in the upcoming years.
China Vaccine Adjuvants Market Analysis :
In China, the market is expected to grow to be worth US$ 534.6 million with an absolute dollar growth of US$ 356.7 million. The market in China has grown at a CAGR of 13.6% from 2018 to 2022 and is expected to grow at a CAGR of 11.6% from 2023 to 2033.
According to WHO, China was significantly affected by the COVID-19 virus, over 9.8 million cases were diagnosed and 119 thousand people died in 2020. The vaccines COVISHIELD and COVAXIN are used for the prevention and treatment of Covid-19. Vaccine Adjuvants such as AS03, MF59, and CpG 1018 have been used in COVID-19 vaccines to enhance their efficacy. This influences market growth.
Japan Vaccine Adjuvants Market Analysis :
In Japan, the market is expected to grow to be worth US$ 437 million with an absolute dollar growth of US$ 279 Million. The market in Japan has grown at a CAGR of 12.2% from 2018 to 2022 and is expected to grow at a CAGR of 10.7% from 2023 to 2033.
In 2018, the number of cancer cases diagnosed in Japan was around 883 thousand while around 409 thousand deaths were reported. The most common cancer in Japan is cervical cancer. Human papillomavirus (HPV) vaccine helps to prevent cervical cancer and other diseases caused by HPV Virus. The adjuvants used in HPV vaccines are aluminum salts, AS04, CpG oligonucleotides, and polysorbate 80. In 2018, the total sales of the Human papillomavirus (HPV) vaccine in Japan were over USD 127 million. The surging demand for vaccines is expected to increase the demand for vaccine adjuvants.
India Vaccine Adjuvants Market Analysis :
The market in India is expected to grow to be worth US$ 267.3 million by 2033, with an absolute dollar growth of US$ 167.6 million. The market in the country has grown at a CAGR of 11.6% from 2018 to 2022 and is expected to grow at a CAGR of 10.4% from 2023 to 2033.
According to research, in 2018, the number of new cases of cervical cancer was about 527 thousand. It is the most common type of cancer in women worldwide and has more death ratio than other cancer. Human papillomavirus (HPV) vaccination is an effective treatment for cervical cancer. These factors are expected to trigger the demand for vaccine adjuvants in the upcoming years.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-Wise Insights
Which Product in the Market is Projected to Witness the Significant Growth?
Demand for adjuvant emulsions is projected to witness significant growth with a CAGR of 14.4% from 2018 to 2022 and is expected to grow at a CAGR of 12.1% from 2023 to 2033.
Adjuvant emulsions are a type of vaccine adjuvant, which are additives added to vaccinations to improve their capacity to stimulate an immune response. Oil and water are combined to form adjuvant emulsions, which promote the distribution of antigens to immune cells and boost the body's defense system, against the vaccine. MF59 is a widely used adjuvant emulsion, which is used for various vaccines such as flu vaccines.
Competitive Analysis
Key players in the market are GSK Plc, Dynavax Technologies, Novavax, Agenus Inc., Croda International Plc, Seppic, Phibro Animal Health Corporation, Spi Pharma, CSL Limited, Merck KGAA, OZ Biosciences, Invivogen, Allergy Therapeutics, Vertellus, and Eubiologics Co. Ltd.
A few of the recent developments in the market are :
- In Oct 2022, GSK acquired Affinivax, a Cambridge-based clinical-stage Biopharmaceutical Company that develops a novel class of vaccines and the most advanced next generation Pneumococcal vaccine.
- In April 2020, Dynavax partnered with Valneva, a French vaccine company, to develop a vaccine for COVID-19. The vaccine uses Dynavax's adjuvant technology.
- In February 2021, Merck extended its collaborative partnership with BioNTech to accelerate the essential lipid supply and amount of its delivery.
Segmentation of the Vaccine Adjuvants Market
-
By Product :
- Adjuvant Emulsions
- Pathogen Components
- Saponin-based Adjuvants
- Particulate Adjuvants
- Other Products
-
By Route of Administration :
- Intramuscular
- Subcutaneous
- Other Route of Administration
-
By Disease Type :
- Infectious Diseases
- Cancer
- Others
-
By Application :
- Research Application
- Commercial Application
-
By End User :
- Human Vaccine Adjuvants
- Veterinary Vaccine Adjuvants
-
By Region :
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018-2022 and Forecast, 2023-2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033 5.3.1. Adjuvant Emulsions 5.3.2. Pathogen Components 5.3.3. Saponin-based Adjuvants 5.3.4. Particulate Adjuvants 5.3.5. Other Products 5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022 5.5. Absolute $ Opportunity Analysis By Product, 2023-2033 6. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Route of Administration 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018-2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023-2033 6.3.1. Intramuscular 6.3.2. Subcutaneous 6.3.3. Other Route of Administration 6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018-2022 6.5. Absolute $ Opportunity Analysis By Route of Administration, 2023-2033 7. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Disease Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Disease Type , 2018-2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Type , 2023-2033 7.3.1. Infectious Diseases 7.3.2. Cancer 7.3.3. Others 7.4. Y-o-Y Growth Trend Analysis By Disease Type , 2018-2022 7.5. Absolute $ Opportunity Analysis By Disease Type , 2023-2033 8. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Application 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018-2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023-2033 8.3.1. Research Application 8.3.2. Commercial Application 8.4. Y-o-Y Growth Trend Analysis By Application, 2018-2022 8.5. Absolute $ Opportunity Analysis By Application, 2023-2033 9. Global Market Analysis 2018-2022 and Forecast 2023-2033, By End Use 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) Analysis By End Use, 2018-2022 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use, 2023-2033 9.3.1. Human Vaccine Adjuvants 9.3.2. Veterinary Vaccine Adjuvants 9.4. Y-o-Y Growth Trend Analysis By End Use, 2018-2022 9.5. Absolute $ Opportunity Analysis By End Use, 2023-2033 10. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022 10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. Asia Pacific 10.3.5. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2018-2022 and Forecast 2023-2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 11.2.1. By Country 11.2.1.1. U.S. 11.2.1.2. Canada 11.2.2. By Product 11.2.3. By Route of Administration 11.2.4. By Disease Type 11.2.5. By Application 11.2.6. By End Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Route of Administration 11.3.4. By Disease Type 11.3.5. By Application 11.3.6. By End Use 11.4. Key Takeaways 12. Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Product 12.2.3. By Route of Administration 12.2.4. By Disease Type 12.2.5. By Application 12.2.6. By End Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Route of Administration 12.3.4. By Disease Type 12.3.5. By Application 12.3.6. By End Use 12.4. Key Takeaways 13. Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 13.2.1. By Country 13.2.1.1. U.K. 13.2.1.2. Spain 13.2.1.3. Germany 13.2.1.4. Italy 13.2.1.5. France 13.2.1.6. Rest of Europe 13.2.2. By Product 13.2.3. By Route of Administration 13.2.4. By Disease Type 13.2.5. By Application 13.2.6. By End Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Route of Administration 13.3.4. By Disease Type 13.3.5. By Application 13.3.6. By End Use 13.4. Key Takeaways 14. Asia Pacific Market Analysis 2018-2022 and Forecast 2023-2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. China 14.2.1.3. Japan 14.2.1.4. Rest of Asia Pacific 14.2.2. By Product 14.2.3. By Route of Administration 14.2.4. By Disease Type 14.2.5. By Application 14.2.6. By End Use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Route of Administration 14.3.4. By Disease Type 14.3.5. By Application 14.3.6. By End Use 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 15.2.1. By Country 15.2.1.1. South Africa 15.2.1.2. GCC Countries 15.2.1.3. Rest of Middle East and Africa 15.2.2. By Product 15.2.3. By Route of Administration 15.2.4. By Disease Type 15.2.5. By Application 15.2.6. By End Use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Route of Administration 15.3.4. By Disease Type 15.3.5. By Application 15.3.6. By End Use 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product 16.1.2.2. By Route of Administration 16.1.2.3. By Disease Type 16.1.2.4. By Application 16.1.2.5. By End Use 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product 16.2.2.2. By Route of Administration 16.2.2.3. By Disease Type 16.2.2.4. By Application 16.2.2.5. By End Use 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product 16.3.2.2. By Route of Administration 16.3.2.3. By Disease Type 16.3.2.4. By Application 16.3.2.5. By End Use 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product 16.4.2.2. By Route of Administration 16.4.2.3. By Disease Type 16.4.2.4. By Application 16.4.2.5. By End Use 16.5. U.K. 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product 16.5.2.2. By Route of Administration 16.5.2.3. By Disease Type 16.5.2.4. By Application 16.5.2.5. By End Use 16.6. Spain 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product 16.6.2.2. By Route of Administration 16.6.2.3. By Disease Type 16.6.2.4. By Application 16.6.2.5. By End Use 16.7. Germany 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product 16.7.2.2. By Route of Administration 16.7.2.3. By Disease Type 16.7.2.4. By Application 16.7.2.5. By End Use 16.8. Italy 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product 16.8.2.2. By Route of Administration 16.8.2.3. By Disease Type 16.8.2.4. By Application 16.8.2.5. By End Use 16.9. France 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product 16.9.2.2. By Route of Administration 16.9.2.3. By Disease Type 16.9.2.4. By Application 16.9.2.5. By End Use 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product 16.10.2.2. By Route of Administration 16.10.2.3. By Disease Type 16.10.2.4. By Application 16.10.2.5. By End Use 16.11. China 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product 16.11.2.2. By Route of Administration 16.11.2.3. By Disease Type 16.11.2.4. By Application 16.11.2.5. By End Use 16.12. Japan 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product 16.12.2.2. By Route of Administration 16.12.2.3. By Disease Type 16.12.2.4. By Application 16.12.2.5. By End Use 16.13. Australia & New Zealand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product 16.13.2.2. By Route of Administration 16.13.2.3. By Disease Type 16.13.2.4. By Application 16.13.2.5. By End Use 16.14. South Africa 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product 16.14.2.2. By Route of Administration 16.14.2.3. By Disease Type 16.14.2.4. By Application 16.14.2.5. By End Use 16.15. GCC Countries 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product 16.15.2.2. By Route of Administration 16.15.2.3. By Disease Type 16.15.2.4. By Application 16.15.2.5. By End Use 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Route of Administration 17.3.4. By Disease Type 17.3.5. By Application 17.3.6. By End Use 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. GSK Plc 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Dynavax Technologies 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Novavax 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Agenus Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Croda International Plc 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Seppic 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Phibro Animal Health Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Spi Pharma 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. CSL Limited 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Merck KGAA 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. OZ Biosciences 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Invivogen 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Allergy Therapeutics 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Vertellus 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.15. Eubiologics Co. Ltd. 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Million) Forecast by Region, 2018-2033
Table 02: Global Market Value (US$ Million) Forecast by Product, 2018-2033
Table 03: Global Market Value (US$ Million) Forecast by Route of Administration, 2018-2033
Table 04: Global Market Value (US$ Million) Forecast by Disease Type , 2018-2033
Table 05: Global Market Value (US$ Million) Forecast by Application, 2018-2033
Table 06: Global Market Value (US$ Million) Forecast by End Use, 2018-2033
Table 07: North America Market Value (US$ Million) Forecast by Country, 2018-2033
Table 08: North America Market Value (US$ Million) Forecast by Product, 2018-2033
Table 09: North America Market Value (US$ Million) Forecast by Route of Administration, 2018-2033
Table 10: North America Market Value (US$ Million) Forecast by Disease Type , 2018-2033
Table 11: North America Market Value (US$ Million) Forecast by Application, 2018-2033
Table 12: North America Market Value (US$ Million) Forecast by End Use, 2018-2033
Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2018-2033
Table 14: Latin America Market Value (US$ Million) Forecast by Product, 2018-2033
Table 15: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2018-2033
Table 16: Latin America Market Value (US$ Million) Forecast by Disease Type , 2018-2033
Table 17: Latin America Market Value (US$ Million) Forecast by Application, 2018-2033
Table 18: Latin America Market Value (US$ Million) Forecast by End Use, 2018-2033
Table 19: Europe Market Value (US$ Million) Forecast by Country, 2018-2033
Table 20: Europe Market Value (US$ Million) Forecast by Product, 2018-2033
Table 21: Europe Market Value (US$ Million) Forecast by Route of Administration, 2018-2033
Table 22: Europe Market Value (US$ Million) Forecast by Disease Type , 2018-2033
Table 23: Europe Market Value (US$ Million) Forecast by Application, 2018-2033
Table 24: Europe Market Value (US$ Million) Forecast by End Use, 2018-2033
Table 25: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018-2033
Table 26: Asia Pacific Market Value (US$ Million) Forecast by Product, 2018-2033
Table 27: Asia Pacific Market Value (US$ Million) Forecast by Route of Administration, 2018-2033
Table 28: Asia Pacific Market Value (US$ Million) Forecast by Disease Type , 2018-2033
Table 29: Asia Pacific Market Value (US$ Million) Forecast by Application, 2018-2033
Table 30: Asia Pacific Market Value (US$ Million) Forecast by End Use, 2018-2033
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018-2033
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2018-2033
Table 33: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2018-2033
Table 34: Middle East and Africa Market Value (US$ Million) Forecast by Disease Type , 2018-2033
Table 35: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2018-2033
Table 36: Middle East and Africa Market Value (US$ Million) Forecast by End Use, 2018-2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Million) by Product, 2023-2033
Figure 02: Global Market Value (US$ Million) by Route of Administration, 2023-2033
Figure 03: Global Market Value (US$ Million) by Disease Type , 2023-2033
Figure 04: Global Market Value (US$ Million) by Application, 2023-2033
Figure 05: Global Market Value (US$ Million) by End Use, 2023-2033
Figure 06: Global Market Value (US$ Million) by Region, 2023-2033
Figure 07: Global Market Value (US$ Million) Analysis by Region, 2018-2033
Figure 08: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 09: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 10: Global Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 13: Global Market Value (US$ Million) Analysis by Route of Administration, 2018-2033
Figure 14: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2023-2033
Figure 15: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2023-2033
Figure 16: Global Market Value (US$ Million) Analysis by Disease Type , 2018-2033
Figure 17: Global Market Value Share (%) and BPS Analysis by Disease Type , 2023-2033
Figure 18: Global Market Y-o-Y Growth (%) Projections by Disease Type , 2023-2033
Figure 19: Global Market Value (US$ Million) Analysis by Application, 2018-2033
Figure 20: Global Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 21: Global Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 22: Global Market Value (US$ Million) Analysis by End Use, 2018-2033
Figure 23: Global Market Value Share (%) and BPS Analysis by End Use, 2023-2033
Figure 24: Global Market Y-o-Y Growth (%) Projections by End Use, 2023-2033
Figure 25: Global Market Attractiveness by Product, 2023-2033
Figure 26: Global Market Attractiveness by Route of Administration, 2023-2033
Figure 27: Global Market Attractiveness by Disease Type , 2023-2033
Figure 28: Global Market Attractiveness by Application, 2023-2033
Figure 29: Global Market Attractiveness by End Use, 2023-2033
Figure 30: Global Market Attractiveness by Region, 2023-2033
Figure 31: North America Market Value (US$ Million) by Product, 2023-2033
Figure 32: North America Market Value (US$ Million) by Route of Administration, 2023-2033
Figure 33: North America Market Value (US$ Million) by Disease Type , 2023-2033
Figure 34: North America Market Value (US$ Million) by Application, 2023-2033
Figure 35: North America Market Value (US$ Million) by End Use, 2023-2033
Figure 36: North America Market Value (US$ Million) by Country, 2023-2033
Figure 37: North America Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 40: North America Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 41: North America Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 42: North America Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 43: North America Market Value (US$ Million) Analysis by Route of Administration, 2018-2033
Figure 44: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2023-2033
Figure 45: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023-2033
Figure 46: North America Market Value (US$ Million) Analysis by Disease Type , 2018-2033
Figure 47: North America Market Value Share (%) and BPS Analysis by Disease Type , 2023-2033
Figure 48: North America Market Y-o-Y Growth (%) Projections by Disease Type , 2023-2033
Figure 49: North America Market Value (US$ Million) Analysis by Application, 2018-2033
Figure 50: North America Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 51: North America Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 52: North America Market Value (US$ Million) Analysis by End Use, 2018-2033
Figure 53: North America Market Value Share (%) and BPS Analysis by End Use, 2023-2033
Figure 54: North America Market Y-o-Y Growth (%) Projections by End Use, 2023-2033
Figure 55: North America Market Attractiveness by Product, 2023-2033
Figure 56: North America Market Attractiveness by Route of Administration, 2023-2033
Figure 57: North America Market Attractiveness by Disease Type , 2023-2033
Figure 58: North America Market Attractiveness by Application, 2023-2033
Figure 59: North America Market Attractiveness by End Use, 2023-2033
Figure 60: North America Market Attractiveness by Country, 2023-2033
Figure 61: Latin America Market Value (US$ Million) by Product, 2023-2033
Figure 62: Latin America Market Value (US$ Million) by Route of Administration, 2023-2033
Figure 63: Latin America Market Value (US$ Million) by Disease Type , 2023-2033
Figure 64: Latin America Market Value (US$ Million) by Application, 2023-2033
Figure 65: Latin America Market Value (US$ Million) by End Use, 2023-2033
Figure 66: Latin America Market Value (US$ Million) by Country, 2023-2033
Figure 67: Latin America Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 70: Latin America Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 71: Latin America Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 72: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 73: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2018-2033
Figure 74: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2023-2033
Figure 75: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023-2033
Figure 76: Latin America Market Value (US$ Million) Analysis by Disease Type , 2018-2033
Figure 77: Latin America Market Value Share (%) and BPS Analysis by Disease Type , 2023-2033
Figure 78: Latin America Market Y-o-Y Growth (%) Projections by Disease Type , 2023-2033
Figure 79: Latin America Market Value (US$ Million) Analysis by Application, 2018-2033
Figure 80: Latin America Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 82: Latin America Market Value (US$ Million) Analysis by End Use, 2018-2033
Figure 83: Latin America Market Value Share (%) and BPS Analysis by End Use, 2023-2033
Figure 84: Latin America Market Y-o-Y Growth (%) Projections by End Use, 2023-2033
Figure 85: Latin America Market Attractiveness by Product, 2023-2033
Figure 86: Latin America Market Attractiveness by Route of Administration, 2023-2033
Figure 87: Latin America Market Attractiveness by Disease Type , 2023-2033
Figure 88: Latin America Market Attractiveness by Application, 2023-2033
Figure 89: Latin America Market Attractiveness by End Use, 2023-2033
Figure 90: Latin America Market Attractiveness by Country, 2023-2033
Figure 91: Europe Market Value (US$ Million) by Product, 2023-2033
Figure 92: Europe Market Value (US$ Million) by Route of Administration, 2023-2033
Figure 93: Europe Market Value (US$ Million) by Disease Type , 2023-2033
Figure 94: Europe Market Value (US$ Million) by Application, 2023-2033
Figure 95: Europe Market Value (US$ Million) by End Use, 2023-2033
Figure 96: Europe Market Value (US$ Million) by Country, 2023-2033
Figure 97: Europe Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 98: Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 99: Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 100: Europe Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 101: Europe Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 102: Europe Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 103: Europe Market Value (US$ Million) Analysis by Route of Administration, 2018-2033
Figure 104: Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023-2033
Figure 105: Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023-2033
Figure 106: Europe Market Value (US$ Million) Analysis by Disease Type , 2018-2033
Figure 107: Europe Market Value Share (%) and BPS Analysis by Disease Type , 2023-2033
Figure 108: Europe Market Y-o-Y Growth (%) Projections by Disease Type , 2023-2033
Figure 109: Europe Market Value (US$ Million) Analysis by Application, 2018-2033
Figure 110: Europe Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 111: Europe Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 112: Europe Market Value (US$ Million) Analysis by End Use, 2018-2033
Figure 113: Europe Market Value Share (%) and BPS Analysis by End Use, 2023-2033
Figure 114: Europe Market Y-o-Y Growth (%) Projections by End Use, 2023-2033
Figure 115: Europe Market Attractiveness by Product, 2023-2033
Figure 116: Europe Market Attractiveness by Route of Administration, 2023-2033
Figure 117: Europe Market Attractiveness by Disease Type , 2023-2033
Figure 118: Europe Market Attractiveness by Application, 2023-2033
Figure 119: Europe Market Attractiveness by End Use, 2023-2033
Figure 120: Europe Market Attractiveness by Country, 2023-2033
Figure 121: Asia Pacific Market Value (US$ Million) by Product, 2023-2033
Figure 122: Asia Pacific Market Value (US$ Million) by Route of Administration, 2023-2033
Figure 123: Asia Pacific Market Value (US$ Million) by Disease Type , 2023-2033
Figure 124: Asia Pacific Market Value (US$ Million) by Application, 2023-2033
Figure 125: Asia Pacific Market Value (US$ Million) by End Use, 2023-2033
Figure 126: Asia Pacific Market Value (US$ Million) by Country, 2023-2033
Figure 127: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 128: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 129: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 130: Asia Pacific Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 131: Asia Pacific Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 132: Asia Pacific Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 133: Asia Pacific Market Value (US$ Million) Analysis by Route of Administration, 2018-2033
Figure 134: Asia Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2023-2033
Figure 135: Asia Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2023-2033
Figure 136: Asia Pacific Market Value (US$ Million) Analysis by Disease Type , 2018-2033
Figure 137: Asia Pacific Market Value Share (%) and BPS Analysis by Disease Type , 2023-2033
Figure 138: Asia Pacific Market Y-o-Y Growth (%) Projections by Disease Type , 2023-2033
Figure 139: Asia Pacific Market Value (US$ Million) Analysis by Application, 2018-2033
Figure 140: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 141: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 142: Asia Pacific Market Value (US$ Million) Analysis by End Use, 2018-2033
Figure 143: Asia Pacific Market Value Share (%) and BPS Analysis by End Use, 2023-2033
Figure 144: Asia Pacific Market Y-o-Y Growth (%) Projections by End Use, 2023-2033
Figure 145: Asia Pacific Market Attractiveness by Product, 2023-2033
Figure 146: Asia Pacific Market Attractiveness by Route of Administration, 2023-2033
Figure 147: Asia Pacific Market Attractiveness by Disease Type , 2023-2033
Figure 148: Asia Pacific Market Attractiveness by Application, 2023-2033
Figure 149: Asia Pacific Market Attractiveness by End Use, 2023-2033
Figure 150: Asia Pacific Market Attractiveness by Country, 2023-2033
Figure 151: Middle East and Africa Market Value (US$ Million) by Product, 2023-2033
Figure 152: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2023-2033
Figure 153: Middle East and Africa Market Value (US$ Million) by Disease Type , 2023-2033
Figure 154: Middle East and Africa Market Value (US$ Million) by Application, 2023-2033
Figure 155: Middle East and Africa Market Value (US$ Million) by End Use, 2023-2033
Figure 156: Middle East and Africa Market Value (US$ Million) by Country, 2023-2033
Figure 157: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 158: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 159: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 160: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 161: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 162: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 163: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2018-2033
Figure 164: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2023-2033
Figure 165: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2023-2033
Figure 166: Middle East and Africa Market Value (US$ Million) Analysis by Disease Type , 2018-2033
Figure 167: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Type , 2023-2033
Figure 168: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Type , 2023-2033
Figure 169: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2018-2033
Figure 170: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 171: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 172: Middle East and Africa Market Value (US$ Million) Analysis by End Use, 2018-2033
Figure 173: Middle East and Africa Market Value Share (%) and BPS Analysis by End Use, 2023-2033
Figure 174: Middle East and Africa Market Y-o-Y Growth (%) Projections by End Use, 2023-2033
Figure 175: Middle East and Africa Market Attractiveness by Product, 2023-2033
Figure 176: Middle East and Africa Market Attractiveness by Route of Administration, 2023-2033
Figure 177: Middle East and Africa Market Attractiveness by Disease Type , 2023-2033
Figure 178: Middle East and Africa Market Attractiveness by Application, 2023-2033
Figure 179: Middle East and Africa Market Attractiveness by End Use, 2023-2033
Figure 180: Middle East and Africa Market Attractiveness by Country, 2023-2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What value is the market estimated to reach in 2023?
The global market size is estimated to be valued at US$ 2.1 Billion in 2023.
What was the global market size for 2022?
The market was reported at US$ 1.9 Billion in 2022.
What valuation is the market estimated to reach by 2033?
The market is expected to reach a valuation of US$ 6.8 Billion by 2033.
What value CAGR did the market exhibit over the last 4 years?
The market registered a CAGR of 14.6% over the last 4 years.
What is the projected Market CAGR from 2023 to 2033?
The market is projected to witness a CAGR of 12.3% from 2023 to 2033.
Which product of vaccine adjuvants is expected to witness significant demand?
Adjuvant emulsions as a top product in the market are projected to witness significant demand with an expected CAGR of 12.1% by 2033.
What is the expected market size in the United States by 2033?
The market in the United States is projected to witness a market size of US$ 2.4 Billion and is expected to grow at a 12% CAGR from 2023 to 2033.
Which are the key companies offering Vaccine Adjuvants?
Key players in the market are GSK Plc, Dynavax Technologies, Novavax, Agenus Inc., Croda International Plc, Seppic, Phibro Animal Health Corporation, Spi Pharma, CSL Limited, Merck KGAA, OZ Biosciences, Invivogen, Allergy Therapeutics, Vertellus, and Eubi
Vaccine Adjuvants Market